These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

873 related articles for article (PubMed ID: 30037330)

  • 1. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.
    Pan Y; Tong JHM; Lung RWM; Kang W; Kwan JSH; Chak WP; Tin KY; Chung LY; Wu F; Ng SSM; Mak TWC; Yu J; Lo KW; Chan AWH; To KF
    Mol Cancer; 2018 Jul; 17(1):102. PubMed ID: 30037330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer.
    Sun M; Song H; Wang S; Zhang C; Zheng L; Chen F; Shi D; Chen Y; Yang C; Xiang Z; Liu Q; Wei C; Xiong B
    J Hematol Oncol; 2017 Mar; 10(1):79. PubMed ID: 28356122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LATS2-mediated YAP1 phosphorylation is involved in HCC tumorigenesis.
    Guo C; Wang X; Liang L
    Int J Clin Exp Pathol; 2015; 8(2):1690-7. PubMed ID: 25973055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-876-5p represses the cell proliferation and invasion of colorectal cancer through suppressing YAP signalling via targeting RASAL2.
    Ren L; Zhang Z; Feng Y; Luo M; Hao Z
    Clin Exp Pharmacol Physiol; 2020 May; 47(5):867-876. PubMed ID: 31990059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis.
    Sun Z; Zhang Q; Yuan W; Li X; Chen C; Guo Y; Shao B; Dang Q; Zhou Q; Wang Q; Wang G; Liu J; Kan Q
    J Exp Clin Cancer Res; 2020 Nov; 39(1):250. PubMed ID: 33218358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of a novel MAP4K4-LATS2-SASH1-YAP1 cascade inhibits tumorigenesis and metastasis in luminal breast cancer.
    Yang P; Li Y; Hou J; Wu D; Zeng X; Zeng Z; Zhang J; Xiong Y; Chen L; Yang D; Wan X; Wu Z; Jia L; Liu Q; Lu Q; Zou X; Fang W; Zeng X; Zhou D
    J Biol Chem; 2024 Jun; 300(6):107309. PubMed ID: 38657867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway.
    Zhou PJ; Xue W; Peng J; Wang Y; Wei L; Yang Z; Zhu HH; Fang YX; Gao WQ
    J Exp Clin Cancer Res; 2017 Oct; 36(1):139. PubMed ID: 29017577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
    Kang W; Huang T; Zhou Y; Zhang J; Lung RWM; Tong JHM; Chan AWH; Zhang B; Wong CC; Wu F; Dong Y; Wang S; Yang W; Pan Y; Chak WP; Cheung AHK; Pang JCS; Yu J; Cheng ASL; To KF
    Cell Death Dis; 2018 Jan; 9(2):92. PubMed ID: 29367737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EXOSC4 functions as a potential oncogene in development and progression of colorectal cancer.
    Pan Y; Tong JHM; Kang W; Lung RWM; Chak WP; Chung LY; Wu F; Li H; Yu J; Chan AWH; To KF
    Mol Carcinog; 2018 Dec; 57(12):1780-1791. PubMed ID: 30155936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
    Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
    Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Hippo Kinase LATS2 Controls Helicobacter pylori-Induced Epithelial-Mesenchymal Transition and Intestinal Metaplasia in Gastric Mucosa.
    Molina-Castro SE; Tiffon C; Giraud J; Boeuf H; Sifre E; Giese A; Belleannée G; Lehours P; Bessède E; Mégraud F; Dubus P; Staedel C; Varon C
    Cell Mol Gastroenterol Hepatol; 2020; 9(2):257-276. PubMed ID: 31669263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased proton-sensing receptor GPR4 signalling promotes colorectal cancer progression by activating the hippo pathway.
    Yu M; Cui R; Huang Y; Luo Y; Qin S; Zhong M
    EBioMedicine; 2019 Oct; 48():264-276. PubMed ID: 31530502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF8 promotes colorectal cancer growth and metastasis by activating YAP1.
    Liu R; Huang S; Lei Y; Zhang T; Wang K; Liu B; Nice EC; Xiang R; Xie K; Li J; Huang C
    Oncotarget; 2015 Jan; 6(2):935-52. PubMed ID: 25473897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CADM1 associates with Hippo pathway core kinases; membranous co-expression of CADM1 and LATS2 in lung tumors predicts good prognosis.
    Ito T; Nakamura A; Tanaka I; Tsuboi Y; Morikawa T; Nakajima J; Takai D; Fukayama M; Sekido Y; Niki T; Matsubara D; Murakami Y
    Cancer Sci; 2019 Jul; 110(7):2284-2295. PubMed ID: 31069869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of hippo pathway in colorectal cancer.
    Liang K; Zhou G; Zhang Q; Li J; Zhang C
    Saudi J Gastroenterol; 2014; 20(3):188-94. PubMed ID: 24976283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMGB1-RAGE signaling facilitates Ras-dependent Yap1 expression to drive colorectal cancer stemness and development.
    Qian F; Xiao J; Gai L; Zhu J
    Mol Carcinog; 2019 Apr; 58(4):500-510. PubMed ID: 30456802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-372-3p promotes tumor progression by targeting LATS2 in colorectal cancer.
    Peng H; Pan X; Su Q; Zhu LS; Ma GD
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8332-8344. PubMed ID: 31646563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulin epithelin precursor promotes colorectal carcinogenesis by activating MARK/ERK pathway.
    Pan Y; Cheung ST; Tong JHM; Tin KY; Kang W; Lung RWM; Wu F; Li H; Ng SSM; Mak TWC; To KF; Chan AWH
    J Transl Med; 2018 Jun; 16(1):150. PubMed ID: 29866109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
    Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
    Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 44.